Promoter holding
64.27%
AP
Avantika Pharma (Distributors) Private Limited - Due diligence report
A 360° intelligence report on Avantika Pharma (Distributors) Private Limited: trust score, financial health, credit view, compliance, direct…
Full Due-Diligence Report + Documents
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
₹700
₹449
Save ₹251
excl. GST
Or from ₹279/report with credits
View credit packages
Company Credits – Starter
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Choose your own credit amount
View credit packages
Avantika Pharma (Distributors) Private Limited — 360° Intelligence Report
Generated from MCA filings & public records88/100
Trust Score
Low Risk
Avantika Pharma (Distributors) Private Limited is assessed as Low Risk with a Trust Score of 88/100. Avantika Pharma (Distributors) Private Limited is an active private limited indian non-government company incorporated in 1981, operating in the Pharma sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and low financial risk profile.
Report generated on 27 Jul 2026 from the latest processed filings. Avantika Pharma (Distributors) Private Limited snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
02
Score Card
Higher is safer · rule-based & explainableTrust ScoreLow Risk
88/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
75/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
95/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
50/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
95/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
80/100
Early-warning signals - higher means fewer warnings.
03
Financial Intelligence Dashboard
Standalone · 5 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
04
Credit & Compliance Intelligence
Why the scores are what they are
Credit Risk Score: 50/100 Moderate
- Liabilities ≈ 38% EBITDA - stretched.
- Open charges exceed net worth - secured lenders rank ahead.
- Moderate gearing (D/E 1.42).
- Profitable - internal accruals available.
Charges position: 3 open (1.82 cr) · 0 satisfied (-).
Banking relationships (from registered charges)
| Lender | Charges | Amount |
|---|---|---|
| Uco Bank | 1 | 48.0 cr |
| Hdfc Bank Limited | 1 | 48.0 cr |
| Vijaya Bank | 1 | 48.0 cr |
Compliance Score: 75/100 Low Risk
- Company status is Active as per MCA.
- Last balance sheet is for Mar 2022 - filings overdue.
- 1 active GST registration(s).
05
Director Intelligence
Stability score: 95/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| ANUJ SHUKLA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| YASHASVI SHUKLA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| NEERAJ SHUKLA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 3 directors on the board.
- No disqualified or deactivated DINs.
- Stable board - no exits in 3 years.
- Average tenure above 5 years.
Director & KMP remuneration (FY 2016)
| Name | Designation | Total remuneration |
|---|---|---|
| A K Sharma | Managing Director | 2.4 cr |
| R Mehta | Whole-time Director | 1.6 cr |
| S Iyer | CFO | 95.0 L |
Remuneration is disclosed in the latest annual return. Unlock full report
06
Ownership & Group Intelligence
As per FY 2021 annual returnPublic / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
1
Capital events
1 allotment(s) · 0 transfer(s)
Promoters hold a dominant controlling stake - exact percentages are part of the full report.
| Group entity | Relationship | % held |
|---|---|---|
| Avantika Motors Private Limited | Associate Company | 74.00% |
Key managerial personnel: NEERAJ SHUKLA (Whole-time director)
Full shareholding pattern, group structure & capital events →
07
Risk Intelligence Center
Growth 95 · Distress 80
Growth signals & trust indicators
Revenue acceleration: +2.1x over 4 year(s).
Latest year revenue grew 24%.
Profit expanded 0.86 year-on-year.
Asset base grew 61% - capacity expansion.
Net margin improved to 38%.
Operating for 44+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Statutory filings appear overdue.
3 open charge(s) registered - assets are encumbered.
08
Stakeholder Verdicts
Vendor · Banker · InvestorVendor due diligence80/100
Favourable indicators
Suitability as a supplier / customer counterparty.
- Statutory record is clean.
- 1 distress signal(s) - see Risk Center.
- Financial filings available for verification.
Banker assessment70/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
- Debt capacity assessed from filed statements.
- 3 open charge(s) of 1.82 cr already registered.
- Compliance record supports lending.
Investor view93/100
Positive growth indicators
Growth quality and scalability through an investor lens.
- 5 growth signal(s) detected.
- Margin and return trends computable from filings.
- Management team looks stable.
09
MCA Filings & Events Timeline
Latest 12 events21 Oct 2023
Charge created
Hdfc Bank Limited - 46.92 Lakh
30 Sep 2022
Last AGM held
Annual general meeting
31 Mar 2022
Latest balance sheet
Filed with ROC
30 Nov 2021
Director ceased
YASHASVI SHUKLA
09 Jun 2021
Director appointed
YASHASVI SHUKLA (Director)
22 May 2021
Director ceased
PANKAJ SHUKLA
25 Mar 2021
Charge created
Uco Bank - 1.25 cr
31 Mar 2014
Securities allotted
30000 Equity Shares Without Differential Rights - 30.00 Lakh raised
07 Aug 2007
Charge created
Vijaya Bank - 10.00 Lakh
01 Apr 1999
Director appointed
ANUJ SHUKLA (Director)
12 Aug 1989
Director appointed
NEERAJ SHUKLA (Whole-time director)
21 Aug 1981
Incorporated
Registered with Roc Kanpur
10
Key Observations
Auto-generated from the data aboveRevenue grew 1.42 over the last 4 financial year(s).
Net profit margin moved from 2.1x to 24%.
Debt-to-equity stands at 0.86 - manageable leverage.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
3 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2021 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 1 security allotment(s) - amounts available in the full report.
| Company | CIN | Location |
|---|---|---|
| Nepco Commercial Pvt. Ltd. | U51909WB1993PTC059652 | Kolkata, West Bengal, India |
| Saturn Formulations Private Limited | U24232CH2013PTC034756 | Chandigarh, Chandigarh, India |
| Garnier Seeds (India) Private Limited. | U01111DL2000PTC104832 | Delhi, Delhi, India |
| Endocard India Private Limited | U24239DL1999PTC098174 | New Delhi, Delhi, India |
| Cine Tekk Electronic & Engineers Private Limited | U51909TN1998PTC040585 | Egmore Nungambakka, Tamil Nadu, India |
| Multiwyn Merchants Private Limited | U51101WB2013PTC192409 | Kolkata, West Bengal, India |
| Starmaxx Distributors Private Limited | U51909PN2018PTC176505 | Kolhapur, Maharashtra, India |
| Liv India Management Private Limited | U74999DL2010PTC205200 | New Delhi, Delhi, India |
12
Who Uses This Report
CA · CS · Banker · Investor · VendorChartered Accountants (CA)
Verify Avantika Pharma (Distributors) Private Limited before audits and certifications: compliance score 75/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Company Secretaries (CS)
Track statutory health of Avantika Pharma (Distributors) Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Bankers & NBFCs
Current banker verdict: Favourable lending indicators. Credit risk score 50/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investors & Analysts
Investor view: Positive growth indicators. Growth score 95/100, margin trends, ownership structure and peer set for Avantika Pharma (Distributors) Private Limited - screening before a deeper diligence.
Vendors & Procurement Teams
Vendor verdict: Favourable indicators. Trust score 88/100, distress signals and MSME payment-delay disclosures - know whether Avantika Pharma (Distributors) Private Limited pays its suppliers before you extend credit terms.
Lawyers & Compliance Teams
Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Avantika Pharma (Distributors) Private Limited - groundwork for KYC, onboarding and disputes.
13
Frequently Asked Questions
Is Avantika Pharma (Distributors) Private Limited an active company?
Avantika Pharma (Distributors) Private Limited has MCA status “Active” with a compliance score of 75/100 (Low Risk).
Is Avantika Pharma (Distributors) Private Limited financially healthy?
Avantika Pharma (Distributors) Private Limited has a Financial Health Score of 95/100 (Low Risk) based on its filed financial statements.
Should I do business with Avantika Pharma (Distributors) Private Limited?
Its overall Trust Score is 88/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Avantika Pharma (Distributors) Private Limited?
Promoters hold a dominant controlling stake - exact percentages are in the full report. 3 active director(s) are on record.
Does Avantika Pharma (Distributors) Private Limited have loans or charges against its assets?
3 open charge(s) are registered against its assets.
Is Avantika Pharma (Distributors) Private Limited up to date with its ROC filings?
Last balance sheet is for Mar 2022 - filings overdue. Overall compliance score: 75/100 (Low Risk).
Is it risky to lend to Avantika Pharma (Distributors) Private Limited?
Its Credit Risk Score is 50/100 (Moderate). Banker verdict: Favourable lending indicators.
Disclaimer: This report is generated automatically from MCA filings and public records as available
in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the
underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are
not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice.
Verify from official sources and consult a qualified professional before any business, lending or investment decision.
If you represent this company and believe any information is inaccurate or outdated,
report it here and we will review promptly.
